Due to the lack of primary MES subtype cell lines, we overexpressed the KRAS-G12C mutant in U87-MG to construct GBM cells with sustained RAS signal activation to simulate MES-GBM characterized by RAS signal activation caused by NF1 mutation. The gene discussed is KRAS; the disease is glioblastoma.